Drug General Information
Drug ID
D03DWG
Former ID
DNC000982
Drug Name
NADPH
Drug Type
Small molecular drug
Indication Discovery agent Investigative [540043]
Structure
Download
2D MOL

3D MOL

Formula
C21H30N7O17P3
InChI
InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m0/s1
InChIKey
ACFIXJIJDZMPPO-NCHANQSKSA-N
CAS Number
CAS 25526-93-6
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:16474
Target and Pathway
Target(s) 3-oxoacyl-[acyl-carrier protein] reductase Target Info Cofactor [535711]
References
Ref 540043(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3041).
Ref 535711Functional characterization of beta-ketoacyl-ACP reductase (FabG) from Plasmodium falciparum. Biochem Biophys Res Commun. 2003 Mar 28;303(1):387-92.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.